Back to PRIMECAP MANAGEMENT CO/CA/ PRIMECAP MANAGEMENT CO/CA/

GSKGSK
16 quarters

Position history for PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/'s holdings in GLAXOSMITHKLINE PLC-SPON ADR

PRIMECAP MANAGEMENT CO/CA/ holds 25.2M shares of GSK (GLAXOSMITHKLINE PLC-SPON ADR), worth $1.3B as of 2026-Q2. The position was decreased (-0.1% shares). GSK represents 0.8% of PRIMECAP MANAGEMENT CO/CA/'s portfolio.

Current Value

$1.3B

Current Shares

25.2M

Total Value Change

+$1.3B

Total Shares Change

+24.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
25.2M
-0.1%
$1.3B0.8%$51.95
0
2026-Q1
Increased
25.2M
+0.3%
$1.4B1.1%$57.07
50
2025-Q4
Decreased
25.1M
-2.5%
$1.2B0.9%$49.30
0
2025-Q3
Decreased
25.8M
-7.1%
$1.1B0.9%$40.74
0
2025-Q2
Increased
27.7M
+7.8%
$1.1B0.8%$36.68
49
2025-Q1
Increased
25.7M
+1.8%
$995.9M0.8%$36.58
46
2024-Q4
Increased
25.3M
+70.1%
$854.3M0.7%$31.59
67
2024-Q3
Increased
14.9M
+2.4%
$607.2M0.4%$37.75
39
2024-Q2
Increased
14.5M
+13.9%
$558.7M0.4%$35.22
43
2024-Q1
Increased
12.7M
+5.4%
$546.1M0.4%$38.90
40
2023-Q4
Increased
12.1M
+0.3%
$448M0.4%$33.30
37
2023-Q3
Increased
12.1M
+2.4%
$437.1M0.4%$32.25
38
2023-Q2
Increased
11.8M
+19.3%
$419.5M0.4%$31.38
44
2023-Q1
Increased
9.9M
+162.1%
$351.2M0.3%$31.03
60
2022-Q4
Increased
3.8M
+753.7%
$132.3M0.1%$30.35
58
2022-Q3
New
441,120
-
$13M0.0%$25.18
39

Other major holders of GSK: FMR LLC, DODGE & COX

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used